Detalles de la búsqueda
1.
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
Expert Rev Pharmacoecon Outcomes Res
; 21(5): 1135-1144, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165377
2.
Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France.
Pharmacoecon Open
; 4(4): 593-603, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043229
3.
Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II.
Clin Cancer Res
; 10(9): 3156-68, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15131057
Resultados
1 -
3
de 3
1
Próxima >
>>